22-50700952-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001372044.2(SHANK3):​c.1798+2149T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.804 in 152,090 control chromosomes in the GnomAD database, including 49,290 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.80 ( 49290 hom., cov: 32)

Consequence

SHANK3
NM_001372044.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.296

Publications

3 publications found
Variant links:
Genes affected
SHANK3 (HGNC:14294): (SH3 and multiple ankyrin repeat domains 3) This gene is a member of the Shank gene family. Shank proteins are multidomain scaffold proteins of the postsynaptic density that connect neurotransmitter receptors, ion channels, and other membrane proteins to the actin cytoskeleton and G-protein-coupled signaling pathways. Shank proteins also play a role in synapse formation and dendritic spine maturation. Mutations in this gene are a cause of autism spectrum disorder (ASD), which is characterized by impairments in social interaction and communication, and restricted behavioral patterns and interests. Mutations in this gene also cause schizophrenia type 15, and are a major causative factor in the neurological symptoms of 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome. Additional isoforms have been described for this gene but they have not yet been experimentally verified. [provided by RefSeq, Mar 2012]
SHANK3 Gene-Disease associations (from GenCC):
  • Phelan-McDermid syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Laboratory for Molecular Medicine
  • schizophrenia 15
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001372044.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK3
NM_001372044.2
MANE Select
c.1798+2149T>C
intron
N/ANP_001358973.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHANK3
ENST00000692848.2
c.1795+2149T>C
intron
N/AENSP00000510794.2A0A8I5KZC4
SHANK3
ENST00000262795.8
TSL:5
c.1213+2149T>C
intron
N/AENSP00000489147.3A0A0U1RQS4
SHANK3
ENST00000414786.8
TSL:5
n.1797+2149T>C
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.804
AC:
122206
AN:
151972
Hom.:
49258
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.799
Gnomad AMI
AF:
0.830
Gnomad AMR
AF:
0.849
Gnomad ASJ
AF:
0.828
Gnomad EAS
AF:
0.645
Gnomad SAS
AF:
0.777
Gnomad FIN
AF:
0.840
Gnomad MID
AF:
0.797
Gnomad NFE
AF:
0.804
Gnomad OTH
AF:
0.800
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.804
AC:
122289
AN:
152090
Hom.:
49290
Cov.:
32
AF XY:
0.804
AC XY:
59788
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.799
AC:
33140
AN:
41476
American (AMR)
AF:
0.849
AC:
12994
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.828
AC:
2869
AN:
3466
East Asian (EAS)
AF:
0.646
AC:
3332
AN:
5160
South Asian (SAS)
AF:
0.777
AC:
3742
AN:
4818
European-Finnish (FIN)
AF:
0.840
AC:
8899
AN:
10598
Middle Eastern (MID)
AF:
0.793
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
0.804
AC:
54647
AN:
67950
Other (OTH)
AF:
0.794
AC:
1678
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1253
2507
3760
5014
6267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
872
1744
2616
3488
4360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.804
Hom.:
163702
Bravo
AF:
0.803
Asia WGS
AF:
0.701
AC:
2440
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
3.7
DANN
Benign
0.31
PhyloP100
-0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2341010; hg19: chr22-51139380; API